/ /

  • linkedin
  • Increase Font
  • Sharebar

    Add-on injectable IOL for pseudophakic AMD maintains near vision


    The SML was implanted in the patients’ better-seeing eye. Vitreous loss occurred in one eye during implantation, but did not affect visual acuity.

    Mean CDVA was 0.18 (decimal) preoperatively and remained unchanged at 3, 6, and 12 months of follow-up. Mean UCNVA at 15 cm improved from 0.25 (decimal) preoperatively to 0.68 at 1 year.

    “These data provide proof of concept that the SML does not affect distance vision but helps to increase near vision,” Dr. Srinivasan said. “But patient selection is key, and postoperative visual training to help patients to read at a distance of 15 cm rather than the traditional 40 cm really seems to help.”

    Mean IOP was 15 mm Hg preoperatively and the same at 1 year after surgery. 
    Three patients experienced distance vision issues with halos and glare, and the SML was explanted in two of those patients. There were no cases of dislocation, chafing effect, iris capture, visual field loss, or other complications.

    Dr. Srinivasan has no relevant financial interest in the SML.


    New Call-to-action


    You must be signed in to leave a comment. Registering is fast and free!

    All comments must follow the ModernMedicine Network community rules and terms of use, and will be moderated. ModernMedicine reserves the right to use the comments we receive, in whole or in part,in any medium. See also the Terms of Use, Privacy Policy and Community FAQ.

    • No comments available


    View Results